10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

☐   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ____________ to ____________

Commission file number: 333-180954

Hawkeye Systems, Inc.

(Exact name of small business issuer as specified in its charter)

Nevada	83-0799093
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

6605 Abercorn, Suite 204

Savannah, GA 31405

(Address of principal executive offices)

(912) 253-0375

(Registrants telephone number, including area code)

____________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act

Title of Each Class	Trading Symbol(s)	Name of each Exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes   ☒ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☐ Yes   ☒ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐	Large accelerated filer	☐	Accelerated filer	☒	Smaller reporting company
		☒	Non-accelerated filer	☒	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Yes   ☒ No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes   ☒ No

The number of shares outstanding of each of the issuer’s classes of common equity as of February 23, 2021 was 16,649,659 shares of common stock.

Contents

		Page
Part 1	FINANCIAL INFORMATION
Item 1	Financial Statements (unaudited)	3
	Condensed Consolidated Balance Sheets as of September 30, 2020 (unaudited) and June 30, 2019	3
	Condensed Consolidated Statements of Operations for the three months ended September 30, 2020 and 2019 (unaudited)	4
	Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended September 30, 2020 and 2019 (unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2020 and 2019 (unaudited)	6
	Notes to the Unaudited Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item 4.	Controls and Procedures	19
Part II.	OTHER INFORMATION
Item 1	Legal Proceedings	20
Item 1A	Risk Factors	20
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 3	Defaults Upon Senior Securities	20
Item 4	Mine Safety Disclosures	20
Item 5	Other Information	20
Item 6	Exhibits	21
	SIGNATURES	22

2

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30,			June 30,
	2020			2020
ASSETS	(Unaudited)
Current assets:
Cash	$	51,256		$	911,747
Accounts receivable		49,471			47,656
Inventory, net		1,371,066			509,517
Prepaid expenses		19,879			6,667
Total current assets		1,491,672			1,475,587
Equipment, net		135			737
Note receivable - Radiant Images, Inc., net of allowance of $1,459,842		-			-
Total assets	$	1,491,807		$	1,476,324
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities	$	517,410		$	332,327
Convertible note payable, net of discount		-			137,625
Convertible note payable, net of discount - related party		224,204			211,305
Note payable - related parties		-			200,000
Common stock payable		9,000			6,000
Common stock payable - related parties		630,000			430,000
Total current liabilities		1,380,614			1,317,257
Total liabilities		1,380,614			1,317,257
Stockholders’ equity:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding		-			-
Common stock, $0.0001 par value, 400,000,000 shares authorized; 15,837,659 and 14,828,036 shares issued and outstanding, respectively		1,584			1,483
Additional paid-in capital		6,934,597			4,527,925
Common stock to be issued - 60,000 and 425,000 shares, respectively		30,000			139,500
Accumulated deficit		(6,854,988	)		(4,509,841	)
Total stockholders’ equity		111,193			159,067
Total liabilities and stockholders’ equity	$	1,491,807		$	1,476,324

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended			Three Months Ended
	September 30,			September 30,
	2020			2019
Sales	$	382,346		$	-
Cost of sales		320,379			-
Gross profit		61,967			-
Operating expenses:
General and administrative		13,797			18,412
Management compensation		153,662			-
Professional fees		38,024			290,485
Professional fees - related party		139,340			-
Marketing		48,418			-
Write-down of inventory		40,164			-
Total operating expenses		433,405			308,897
Loss from operations		(371,438	)		(308,897	)
Other expense:
Interest expense		(26,833	)		-
Interest expense - related party		(12,899	)		-
Financing expense		(55,497	)		-
Financing expense - related party		(1,508,211	)		-
Loss on settlement of debt		(370,269	)		-
Total other expense		(1,973,709	)		-
Net loss	$	(2,345,147	)	$	(308,897	)
Net loss per common share - basic and diluted	$	(0.15	)	$	(0.03	)
Weighted average common shares outstanding - basic and diluted		15,562,663			11,164,921

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

For the Three Months Ended September 30, 2020

							Common
					Additional		Stock
	Common Stock				Paid-in		to be			Accumulated			Stockholders’
	Shares		Amount		Capital		Issued			Deficit			Equity
Balance, June 30, 2020		14,828,036	$	1,483	$	4,527,925	$	139,500		$	(4,509,841	)	$	159,067
Common shares issued for stock to be issued		365,000		37		109,463		(109,500	)		-			-
Warrants exercised for cash		175,000		17		67,483		-			-			67,500
Common shares issued for conversion of debt		469,623		47		525,931		-			-			525,978
Stock based compensation – options		-		-		119,155		-			-			119,155
Stock based compensation – warrant		-		-		1,563,708		-			-			1,563,708
Debt forgiveness		-		-		20,932		-			-			20,932
Net loss		-		-							(2,345,147	)		(2,345,147	)
Balance, September 30, 2020		15,837,659	$	1,584	$	6,934,597	$	30,000		$	(6,854,988	)	$	111,193

For the Three Months Ended September 30, 2019

							Common
					Additional		Stock
	Common Stock				Paid-in		To Be			Accumulated			Stockholders’
	Shares		Amount		Capital		Issued			Deficit			Equity
Balance, June 30, 2019		9,897,116	$	990	$	2,198,891	$	170,000		$	(1,909,373	)	$	460,508
Common stock issued for cash		449,333		45		40,538		-			-			40,583
Common stock issued as compensation		1,222,000		116		540,872		-			-			540,988
Warrants issued		617,333		-		7,511		-			-			7,511
Stock options		100,000		-		1,918		-			-			1,918
Stock subscription received		-		-		-		43,000			-			43,000
Stock subscription receivable		-		-		-		(2,787	)		-			(2,787	)
Net loss		-		-		-		-			(308,897	)		(308,897	)
Balance, September 30, 2019		12,285,782	$	1,151	$	2,789,730	$	210,213		$	(2,218,270	)	$	782,824

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

HAWKEYE SYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended			Three Months Ended
	September 30,			September 30,
	2020			2019
Cash flows from operating activities:
Net loss	$	(2,345,147	)	$	(308,897	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		602			603
Write-down of inventory		40,164			-
Loss on settlement of debt		370,269			-
Amortization of debt discount		25,274			-
Stock based compensation – options and warrant		1,682,863			-
Common stock issued and warrants exercised for services		-			260,000
Change in operating assets and liabilities:
Accounts receivable		(1,815	)		-
Inventory		(901,713	)		-
Prepaid expense		(13,212	)		4,855
Accounts payable and accrued liabilities		211,724			(20,369	)
Common stock payable		3,000			-
Net cash used in operating activities		(927,991	)		(63,808	)
Cash flows from investing activities:
Shares issued for Radiant Images, Inc. deposit		-			70,000
Investment in Radiant Images, Inc.		-			(114,000	)
Net cash used in investing activities		-			(44,000	)
Cash flows from financing activities:
Sales of common stock and warrants, net of issuance costs		-			50,000
Proceeds from exercise of warrants		67,500			-
Stock subscription receivable					(2,787	)
Stock subscriptions received		-			43,000
Net cash provided by financing activities		67,500			90,213
Net change in cash		(860,491	)		(17,595	)
Cash beginning of period		911,747			18,372
Cash end of period	$	51,256		$	777
Supplemental cash flow information
Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-
Non-cash investing and financing activities:
Common stock issued on conversion of note payable	$	525,978		$	-
Reclassification from note payable related party to stock payable	$	200,000		$	-
Reclassification from common stock to be issued to common stock	$	109,500		$	-
Debt forgiveness	$	20,932		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

HAWKEYE SYSTEMS, INC.

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

Note 1 – Summary of Significant Accounting Policies

Basis of presentation

The accompanying unaudited condensed interim financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2020, as filed with the SEC on February 1, 2021.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

Accounts receivable and allowance for doubtful accounts

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in its existing accounts receivable. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments for services or goods. Accounts with known financial issues are first reviewed and specific estimates are recorded. The remaining accounts receivable balances are then grouped in categories by the number of days the balance is past due, and the estimated loss is calculated as a percentage of the total category based upon past history. Account balances are charged against the allowance when it is probable that the receivable will not be recovered. The Company had no allowance for doubtful accounts at September 30, 2020 or June 30, 2020.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

7

Revenue recognition

Revenue is recorded in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Revenue is recognized from product sales when goods are shipped, title and risk of loss have transferred to the purchaser, there are no significant vendor obligations, the fees are fixed or determinable, and collection is reasonably assured. Amounts billed to customers for shipping and handling are included in net sales. Costs associated with shipping and handling are included in cost of goods sold. The Company recognizes sales on a gross basis when it is considered the primary obligor in the transaction and on a net basis when it is considered to be acting as an agent. We record estimates for cash discounts, product returns, and other discounts in the period of the sale. This provision is recorded as a reduction from gross sales and the reserves are shown as a reduction of accounts receivable.

Cost of sales

Cost of sales includes inventory costs and shipping and freight expenses.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable. For the three months ended September 30, 2020 and 2019, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	September 30,		September 30,
	2020		2019
Warrants		8,939,131		15,272,997
Options		5,255,000		772,000
Convertible notes		1,000,000		200,000
Total possible dilutive shares		15,194,131		16,244,997

Reclassification

Certain amounts from prior periods have been reclassified to conform to the current period presentation. The reclassification have no effect on previously reported results of operations or cash flows.

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

Note 2 – Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the three month period ended September 30, 2020, the Company had a net loss of $2,345,147. As of September 30, 2020, the Company had an accumulated deficit of $6,854,988. The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan.

8

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 3 – Inventory

Inventory at September 30, 2020 and June 30, 2020 consists of the following:

	September 30,			June 30,
	2020			2020
Finished goods	$	1,537,230		$	545,112
Goods in transit		-			90,405
Less: Obsolescence		(166,164	)		(126,000	)
Inventory, net	$	1,371,066		$	509,517

During the year ended June 30, 2020, the Company purchased inventory of $153,000 for issuance of common stock. As at September 30, 2020 and June 30, 2020, the Company recorded $153,000 common stock payable.

Note 4 – Advances to Radiant Images, Inc.

Note Receivable – Radiant Images, Inc.

In contemplation of the closing of the Radiant Agreement, the advance balance of $920,800 was formalized in a secured revolving promissory note (“Radiant Note)” dated April 26, 2019. Further advances to Radiant prior to the closing of the acquisition would increase the balance of the promissory note. The interest rate on the note was 12% and accrues daily on the outstanding balance and is collateralized by all of the assets of Radiant pursuant to a Security Agreement. The purchase price would be offset by the balance of the promissory note and interest upon closing. Through June 30, 2020, additional cash advances under the note receivable totaled $385,000 in equity-related transactions.

In April 2020, the Company received notice from Radiant of its intent to terminate the Radiant Agreement. As per terms of the agreement, the Radiant Note and related interest became due. The Company has ceased further discussions with respect to the acquisition and is pursuing litigation for repayment of amounts due by Radiant. The Company’s investment in Radiant was structured as a revolving note and has been classified as a Note Receivable from Radiant due with accrued but unpaid interest. Pursuant to the terms of the revolving note, Radiant is required to repay the money already invested to Hawkeye with interest. The note receivable was issued on April 26, 2019, is due upon demand of the Company at any time commencing April 26, 2020. The interest rate on the note is 12% and accrues daily on the outstanding balance. During the fiscal year ended June 30, 2020, total contributions of $337,000 were made to Radiant, bringing the balance of the note receivable to $1,305,800 at June 30, 2020 (not including interest). Because of the ongoing litigation with Radiant, the Company recorded an allowance for note receivable of $1,305,800 and interest receivable of $154,042, during the year ended June 30, 2020. The Company has not calculated any additional interest or allowance for the three months ended September 30, 2020. Nevertheless, the Company intends to vigorously pursue the litigation and expects to fully collect these amounts from Radiant and/or its principals.

9

As of September 30, 2020 and June 30, 2020, note receivable and interest receivable are as follows:

	September 30,			June 30,
	2020			2020
Note receivable	$	1,305,800		$	1,305,800
Interest receivable		154,042			154,042
		1,459,842			1,459,842
Allowance for note receivable		(1,305,800	)		(1,305,800	)
Allowance for interest receivable		(154,042	)		(154,042	)
	$	-		$	-

Note 5 – Note Payable – Related Party

On June 13, 2019, the Company entered into a Securities Purchase Agreement with a shareholder pursuant to which it issued a Promissory Note for $200,000 due on the second anniversary of issuance. The note bears interest at 10%. In connection with the Securities Purchase Agreement, the Company issued 100,000 shares of its common stock and a warrant to purchase 400,000 shares at $1.50 per share exercisable for two years from issuance.

On June 13, 2020, the note matured, became due on demand and as a condition of maturity became convertible with a 40% discount to market price, but not lower than $1.00 per share.

On July 1, 2020, the Company and note holder agreed to convert the note of $200,000 into 800,000 shares of common stock and accrued interest of $20,932 was forgiven. As a result, the Company reclassed note payable – related party of $200,000 to common stock payable and recorded debt forgiveness of $20,932 as additional paid in capital.

Note 6 – Convertible Notes Payable

Convertible note

On March 17, 2020, the Company entered into a Securities Purchase Agreement with Eagle Equities LLC pursuant to which the Company issued a 10% Convertible Redeemable Note (“Convertible Note”) for the original principal amount of $150,000. The Convertible Note is due on March 17, 2021 and on the sixth month anniversary of the Note may be converted into shares of Common Stock of the Company at a 40% discount to the lowest Volume Weighted Average Price for the Company’s common stock for the 15 days preceding the conversion. The Convertible Note may be prepaid prior to the six-month anniversary at 115% of the face if paid within 30 days, and an additional 5% every 30 days thereafter with a cap of 140%. Interest accrual and debt amortization would have begun in April 2020.

Financing fees associated with the note totaled $16,500 resulting in net proceeds to the Company of $133,500. The financing fees were recognized as a discount on debt is being amortized over the term of the note.

On August 4, 2020, the note of $150,000 and accrued interest of $5,708 were converted into 469,623 shares of common stock resulting in a loss of settlement of debt totaling $370,269.

During the three months ended September 30, 2020, amortization of $12,375 was recognized as interest expense. As of September 30, 2020 and June 30, 2020, the balance of the note payable is $0 and $150,000 less unamortized debt discount of $0 and $12,375, respectively. Interest expense of $1,958 was recognized on the convertible note during the three months ended September 30, 2020.

10

Convertible note – related party

On April 6, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on April 6, 2021. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25 per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $13,297 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $51,594, which is being amortized over the term of the note.

During the three months ended September 30, 2020, amortization of $12,899 was recognized as interest expense. As of September 30, 2020 and June 30, 2020, the balance of the note payable is $250,000 less unamortized debt discount of $25,796 and $38,695 or $224,204 and $211,305, respectively. Interest expense of $12,500 was recognized on the convertible notes during the three months ended September 30, 2020.

Note 7 – Common stock payable

As of September 30, 2020 and June 30, 2020, common stock payable are as follows:

	September 30,		June 30,
	2020		2020
Purchase of inventory – related party	$	153,000	$	153,000
Related parties		477,000		277,000
Commitments		9,000		6,000
	$	639,000	$	436,000

Note 8 – Stockholders’ Equity

Common Stock

During the three months ended September 30, 2020, the Company had the following common stock transactions:

• Issued 469,623 shares of its common stock in exchange for conversion of debt and accrued interest of $525,978.

• Issued 175,000 shares of its common stock associated with the exercise of warrants for $67,500.

• Issued 365,000 shares of common stock for stock subscriptions of $109,500 received prior to June 30, 2020.

During the three months ended September 30, 2019 the Company had the following common stock transactions:

• Effective July 3, 2019 the Company issued 333,333 shares to an accredited investor for $50,000. As part of the investment, the investor was also issued 333,333 warrants to purchase shares of common stock for two years at $.50 per share and 100,000 options to purchase shares of common stock for two years at $.25 per share

• On July 19, 2019 the Company issued 260,000 shares to Michael Mansouri and 260,000 shares to Gianna Wolfe as consulting expense in connection with the acquisition of Radiant Images, Inc.

• Effective July 28, 2019 the Company issued 200,000 shares to a related party in consideration for the payment of $50,000 to the Joint Venture, 80,000 shares to an accredited investor in consideration for $20,000 paid on behalf of the Joint Venture, and 22,000 shares to a related party for legal services valued at $11,000.

• On August 2, 2019 the investor who acquired a note on January 22, 2019 converted that note to 400,000 shares of common stock.

• Effective July 9, 2019 an investor subscribed to purchase: (i) 60,000 shares of common stock, and (ii) 60,000 Series C Warrants that are exercisable for 2 years from this date for an exercise price of $.50 per share. The purchase is at a price of $.25 per unit, for a total purchase price of $15,000, of which $2,787 was receivable at September 30, 2019.

• On September 10, 2019 the Company sold 56,000 shares to an accredited investor for $28,000. Included with the purchase was warrants to 112,000 shares at $1.00 per year for two years and warrants to purchase 112,000 shares at $2.00 per year for two years.

11

Common Stock to be Issued

As of September 30, 2020 and June 30, 2020, the Company received payment for unissued capital stock resulting in 60,000 and 425,000 share of common stock to be issued for payments of $30,000 and $139,500, respectively.

Balance at June 30, 2020		139,500
Received on subscription		-
Common stock certificates issued		(109,500	)
Balance at September 30, 2020	$	30,000

Stock Purchase Warrants

Transactions in stock purchase warrants for the three months ended September 30, 2020 are as follows:

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2020		7,047,135		$	1.52
Granted		2,178,996		$	1.10
Exercised – shares issued		(175,000	)	$	0.39
Expired		(112,000	)	$	1.00
Balance at September 30, 2020		8,939,131		$	1.57

The composition of the Company’s warrants outstanding at September 30, 2020 are as follows:

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		349,998		3,58
$	0.50		1,059,999		2.53
$	1.00		3,097,317		1.25
$	1.50		20,000		1.00
$	2.00		4,260,666		1.44
$	2.50		151,151		0.27
			8,939,131		1.57

During the three months ended September 30, 2020, the Company issued 2,178,996 warrants to purchase common stock. The fair value of the warrants was determined using the Black-Scholes option pricing model with the following assumptions:

	Three months ended September 30, 2020			Year ended June 30, 2020			Year ended June 30, 2019
Exercise price	$	0.30 to 2.00		$	1.00		$	1.00 to $2.00
Expected term (in years)	0.04 – 2.00 years			1.00 years			0.75 years
Risk-free rate	0.12 – 0.17		%	0.13 to 0.18		%		2.00	%
Volatility	440 - 660		%	111 to 190		%		233	%
Dividend yield		-			-			-

During the three months ended September 30, 2020, $1,563,708 was expensed for the extension of warrants that had expired, of which $1,508,211 was to a related party.

Stock Options

During the three months ended September 30, 2020 and year ended June 30, 2020, 0 and 3,800,000 options were granted, respectively.

12

The fair value of the options was determined using the Black-Scholes option pricing model with the following assumptions:

	June 30,
	2020
Trading price	$	0.06-$0.47
Exercise price	$	0.10-$0.50
Expected term (in years)	1.0 to 5.0
Risk-free rate	0.19%-2.46
Volatility	97%-174
Dividend yield		-

The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of the awards in effect at the time of grant. The Company has no history or expectation of paying cash dividends on its common stock.

Transactions in stock options for the three months ended September 30, 2020 are as follows:

	Number of options		Weighted average exercise price		Weighted average remaining life (in years)
Outstanding, June 30, 2020		5,255,000	$	0.25		4.28
Granted		-		-		-
Expired or Forfeited		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2020		5,255,000		0.25		4.03
Vested, September 30, 2020		3,815,000	$	0.29		3.86

During the three months ended September 30, 2020, $119,155 was expensed, of which $85,100 was to related parties, and as of September 30, 2020, $238,307 remains unamortized, of which $170,198 is with related parties.

At September 30, 2020, the intrinsic value of the 5,255,000 outstanding options was $1,424,127.

Note 9 – Related Party Transactions

As of September 30, 2020 and June 30, 2020, the Company recorded $277,000 in common stock payable to a related party investor.

Note 10 – Commitments and Contingencies

On August 1, 2019, the Company entered into an agreement with Stratcon Advisory and Tysadco Partners. Pursuant to the agreement, the Company will pay $6,000 per month for twelve months for corporate development, investment advisory, and investor relations services, payable $3,000 in restricted common stock and $3,000 in cash. Total expense recognized under this agreement during the three months ended September 30, 2020 and 2019 was $6,000 and $12,000, respectively. As of September 30, 2020 and June 30, 2020, the Company had a balance of $30,000 and $27,000 in accounts payable and $9,000 and $6,000 worth of common stock payable, respectively.

13

On June 11, 2020, the Company formalized an employment agreement with its chief executive officer which provides for annual salary of $250,000 beginning with the calendar year 2020. The agreement also specified that the CEO would receive $180,000 of salary that was earned during the calendar year 2019. During the three months ended September 30, 2020, compensation expense of $30,000 was recognized under this agreement. As of September 30, 2020 and June 30, 2020, the Company has a payable due to its CEO of $30,000 and $150,000, respectively. The agreement contained provisions for severance, health benefits, and a car allowance.

Note 11 – Subsequent Events

Effective November 25, 2020, the Company’s chief executive officer converted $180,000 of unpaid salary into 515,000 shares of common stock.

Effective December 3, 2020, the Company issued 100,000 shares of common stock to an accredited investor for $20,000. Included with the purchase were 100,000 options to purchase common stock at $0.20 per share exercisable for two years.

Effective December 15, 2020, the Company issued 612,000 shares of common stock to an accredited investor upon conversion of $153,000 in debt.

Effective December 15, 2020, the Company issued a 1 year convertible promissory note for $250,000. The promissory note incurs interest at 10%, if repaid within 90 days, and simple interest at 20% per annum thereafter. At the option of the holder this note is convertible at any time which is six months from the date of the issuance through the date which is one year from the date of issuance at a conversion price of $0.25 per share. Included with the convertible promissory note were 100,000 options to purchase common stock at $0.25 per share exercisable for two years.

On February 19, 2021, a related party advanced $1 million to the Company. The purpose of the advance is to purchase inventory to satisfy a customer order. The advance will be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction.

14

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

The following discussion relates to the historical operations and financial statements of Hawkeye Systems, Inc. for the three months ended September 30, 2020 and 2019.

Forward-Looking Statements

The following Management’s Discussion and Analysis should be read in conjunction with our financial statements and the related notes thereto included elsewhere in this Annual Report. The Management’s Discussion and Analysis contains forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect,” and the like, and/or future-tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements in this Annual Report. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading “Risks Factors” in our various filings with the Securities and Exchange Commission. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Annual Report.

Financial Condition and Results of Operations

We have incurred recurring losses to date. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We expect we will require additional capital to meet our long term operating requirements. We expect to raise additional capital through, among other things, the sale of equity or debt securities.

Results of Operations

Three Months Ended September 30, 2020 compared to three months ended September 30, 2019

We had operating revenues of $382,346 for the three months ended September 30, 2020 compared with no revenues for the comparable period in 2019. Our activities have been financed by the proceeds of share subscriptions, exercises of warrants and loans. During the three months ended September 30, 2020, we raised approximately $67,500 from the exercise of warrants.

Total operating expenses in the three month period ended September 30, 2020 were $433,405 compared to $308,897 in the comparable period in 2019. The operating loss for the three months ended September 30, 2020, is principally the result of management compensation paid in connection with the Company’s operations, together with legal and professional fees and marking expenses. For the three months ended September 30, 2019, operating losses were primarily from professional fees of $290,485.

Our financial statements reflect a net loss of $2,345,147 for the three month period ended September 30, 2020 compared to a net loss of $308,897 for the comparable period in 2019. This net loss again reflects management compensation and legal and professional expenses during the periods and a non-operating expense of $1.5 million, which related to the issuance of warrants in the three months ended September 30, 2020.

Liquidity and Capital Resources

The following table provides selected financial data about our company as of September 30, 2020 and June 30, 2020, respectively.

15

	September 30,		June 30,
	2020		2020		Change
Cash	$	51,256	$	911,747	$	(860,491	)
Current assets	$	1,491,672	$	1,475,587	$	16,085
Current liabilities	$	1,380,614	$	1,317,257	$	63,357
Working Capital	$	111,058	$	158,330	$	(47,272	)

Our cash balance at September 30, 2020 was $51,256. We continue to raise funds from the sale of equity securities to investors, exercises of warrants and through issuance of notes. Beginning in early 2020, we also commenced the receipt of revenues from sales of our PPE products. We do not believe the cash reserves are sufficient to cover our expenses for our operations for fiscal year ending June 30, 2021. We will require additional funding for our ongoing operations.

We intend to raise funds through private placements and the exercise of warrants issued in private placements. Although to date we have had some warrant exercises for cash, there can be no assurance that we will be able to raise money through private offerings or through the exercise of warrants. If we cannot raise any additional financing prior to the expiration of the fiscal year ending June 30, 2021, we believe we will be able to obtain funding from private investment firms and/or lenders, if necessary, but have no agreement in writing.

We are an emerging growth company and have generated limited revenue to date. Under a limited operations scenario to maintain our corporate existence, we will require additional funds over the next 12 months to complete our regulatory reporting and filings. However, we will require maximum participation in private offerings or through alternative financings to implement our complete business plan.

There are no assurances that we will be able to obtain further funds required for our continued operations. Even if additional financing is available, it may not be available on terms we find favorable. Failure to secure the needed additional financing will have an adverse effect on our ability to remain in business.

Cash Flows

	Three months ended
	September 30,						Change
	2020			2019			Amount
Cash flows (used in) operating activities	$	(927,991	)	$	(63,808	)	$	(864,183	)
Cash flows (used in) investing activities		-			(44,000	)		44,000
Cash flows provided by financing activities		67,500			90,213			(22,713	)
Net change in cash during period	$	(860,491	)	$	(17,595	)	$	(842,896	)

Cash Flow from Operating Activities

As of September 30, 2020, we had not generated positive cash flow from operating activities. For the three months ended September 30, 2020, net cash flows used by operating activities was $928,000 compared to $64,000 used during the three months ended September 30, 2019. Cash flows used by operating activities for the three months ended September 30, 2020, comprised of a net loss of $2.4 million, which was reduced by non-cash expenses of $2.1 million, primarily from $1.7 million for stock based compensation for depreciation, and was increased by a net change in working capital of $662,000.

Cash flows used in operating activities for the three months ended September 30, 2019, comprised of a net loss of $309,000, which was reduced by non-cash expenses of $261,000, for $603 depreciation and $260,000 for stock-based compensation and a net change in working capital of $15,000.

16

Cash Flows from Investing Activities

During the three months ended September 30, 2020, we did not use cash for investing activities. During the three months ended September 30, 2019, we used $44,000 for the investment in Radiant Images, Inc.

Cash Flows from Financing Activities

We have financed our operations primarily from the issuance of equity instruments. For the three months ended September 30, 2020, net cash provided by financing activities was $67,500, consisting of the proceeds from the exercise of warrants. For the three months ended September 30, 2019, net cash provided by financing activities was $90,000, consisting mostly of proceeds from the sale of shares of our common stock $50,000 and stock subscriptions received of $43,000.

Plan of Operation and Funding

We expect that working capital requirements will continue to be funded through equity offerings, warrant exercises, and related party advances in the near term. We have no guarantees or firm commitments that the related party advances will continue in the near term. Our working capital requirements are expected to increase with the growth of our business.

Existing working capital, further advances, together with anticipated capital raises, warrant exercises and anticipated cash flow are expected to be adequate to fund our operations over the next twelve months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through proceeds from the sale of our common stock, warrant exercises and convertible loans.

Management anticipates additional increases in operating expenses and capital expenditures relating to: (i) funding our PPE purchases and sales; (ii) developmental expenses; and (iii) marketing expenses. We intend to finance these expenses with issuances of securities, funding agreements with third parties for PPE products, and through the exercise of outstanding warrants.

Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations.

Effective April 2, 2020 the Company’s agreement with Radiant Images was terminated. The Company has engaged counsel and will be bringing legal action against Radiant for numerous causes of action, including breach of contract and fraud. The investment was structured as a revolving note and as a consequence the company has reclassified the Investment in Radiant as a Note Receivable from Radiant. Pursuant to the terms of the revolving note, Radiant is required to repay the money we have already invested to Hawkeye. The note receivable is due upon demand of the Company at any time commencing April 26, 2020 and is payable with 12% interest.

In December 2019 coronavirus (COVID-19) emerged in Wuhan, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to almost all other countries, including the United States, and infections have been reported globally.

Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. Additional, more restrictive proclamations and/or directives may be issued in the future.

The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but may have a material impact on our business, financial condition and results of operations.

17

The significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.

Because of the COVID-19 pandemic, the Company has focused on pandemic management products and services.

The Company has continued its focus on sourcing and delivering other PPE products, including without limitation masks, nitrile gloves, gowns, and sanitizer. The Company has numerous transactions in progress and anticipates significant additional sales of PPE products during 2021.

Material Commitments

As of the date of this Current Report, we do not have any material commitments.

Purchase of Significant Equipment

While we maintain some inventory of PPE products, we do not intend to purchase any significant equipment during the next twelve months.

Application of Critical Accounting Policies

We have identified the policies below as critical to our business operations and the understanding of our results of operations. The impact on our business operations and any associated risks related to these policies are discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported or expected financial results.

In the ordinary course of business, we have made a number of estimates and assumptions relating to the reporting of results of operations and financial condition in the preparation of our financial statements in conformity with U.S. GAAP. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The results form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe that the following discussion addresses our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations and require our most difficult, subjective, and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

The material estimates for our company are that of the stock-based compensation recorded for options and financing expenses for warrants. The fair values of options and warrants are determined using the Black-Scholes option pricing model. We have no historical data on the accuracy of these estimates. The estimated sensitivity to change is related to the various variables of the Black-Scholes option pricing model. The specific quantitative variables are included in the notes to the consolidated financial statements.

We prepare our financial statements in conformity with U.S. GAAP, which requires management to make certain estimates and apply judgments. We base our estimates and judgments on historical experience, current trends and other factors that management believes to be important at the time the financial statements are prepared. On a regular basis, we review our accounting policies and how they are applied and disclosed in our financial statements.

While we believe that the historical experience, current trends and other factors considered support the preparation of our financial statements in conformity with GAAP, actual results could differ from our estimates and such differences could be material.

18

For our critical accounting policies and estimates for “Revenue Recognition” see Note 1, Summary of Significant Accounting Policies, to the unaudited Condensed Consolidated Financial Statements in Item 1 of Part I of this Quarterly Report. Other than the policy changes disclosed in Note 1, Summary of Significant Accounting Policies, to the unaudited Condensed Consolidated Financial Statements in Item 1 of Part I of this Quarterly Report, there have been no material changes to our critical accounting policies and estimates during the three months ended September 30, 2020 from those disclosed in our Annual Report on Form 10-K for the year ended June 30, 2020.

Off-Balance Sheet Arrangements

As of the date of this Current Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Management’s Annual Report on Internal Control over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes of accounting principles generally accepted in the United States.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

Our management evaluated the effectiveness of the Company’s internal control over financial reporting as of September 30, 2020. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework. Based on this evaluation, our management, consisting of a sole officer and two directors at that time, concluded that, as of September 30, 2020, our internal control over financial reporting were not effective.

In response to that assessment we made a determination that accounting and financial reporting services which were outsourced to a consulting firm were insufficient. As a consequence, we made the determination that we need to dedicate more of the company’s current and future financial resources to this function and in January 2021 we engaged a Chief Financial Officer.

19

PART II – OTHER INFORMATION

Item 1 – Legal Proceedings

On November 13, 2019, 5W Public Relations LLC filed a complaint against Hawkeye Systems, Inc. relating to payments allegedly due under a contract for public relations services. Hawkeye vigorously disputes the allegations in the complaint as 5W Public Relations provided virtually no services to Hawkeye during the term of this arrangement but was paid a substantial amount of funds. Hawkeye has engaged counsel to defend the litigation and also assert counterclaims for failure of consideration, fraud in the inducement, general fraud and other causes of action. Hawkeye anticipates that this litigation if pursued will be resolved favorably for the Company. 

Hawkeye has engaged counsel and intends to bring legal action against Radiant Images, Inc. as well as its two principals, Michael Mansouri and Gianna Wolfe, for numerous causes of action including fraud, fraudulent inducement, unjust enrichment and numerous other matters in connection with our agreement with them. We are currently working to replevin shares of stock issued to them and to recover funds payable pursuant to a promissory note due to us from Radiant.

We are not aware of any other legal proceedings contemplated by any governmental authority or any other party involving us or our properties. As of the date of this report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any other legal proceedings pending or that have been threatened against us or our properties.

From time to time the Company may be named in claims arising in the ordinary course of business. Currently, no legal proceedings or claims, other than those disclosed above, are pending against or involve the Company that, in the opinion of management, could reasonably be expected to have a material adverse effect on its business and financial condition.

Item 1A – Risk Factors

Not required for Smaller Reporting Companies.

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

Effective July 1, 2020, the Company agreed to change the conversion price and issue 800,000 shares of common stock to an accredited investor upon conversion of a $200,000 convertible note at $0.25 per share.

Effective July 7, 2020, the Company issued 100,000 shares of common stock to an accredited investor upon the exercise of warrants at $0.30 per share.

Effective July 21, 2020, the Company issued 100,000 shares of common stock to an accredited investor upon the exercise of warrants at $0.30 per share.

On September 23, 2020 Eagle Equities LLC converted in full its outstanding convertible note with an original principal amount of $150,000, together with accrued and unpaid interest, into 469,623 shares of common stock.

Effective November 25, 2020, the Company’s chief executive officer converted $180,000 of unpaid salary into 515,000 shares of common stock.

Effective December 3, 2020, the Company issued 100,000 shares of common stock to an accredited investor for $20,000. Included with the purchase were 100,000 warrants to purchase common stock at $.20 per share exercisable for two years.

Effective December 15, 2020, the Company issued 612,000 shares of common stock to an accredited investor upon conversion of $153,000 in debt.

The proceeds of these sales were utilized in operations and for PPE purchases and sales.

Item 3 – Defaults Upon Senior Securities

No disclosure required.

Item 4 – Mine Safety Disclosure

No disclosure required.

Item 5 – Other Information

No disclosure required.

20

Item 6. EXHIBITS

Exhibits:

Number	Description
31.1	Certification of Chief Executive Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant Section 302 of the Sarbanes Oxley Act of 2002
31.2	Certification of Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant Section 302 of the Sarbanes Oxley Act of 2002
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101. DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

21

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Hawkeye Systems, Inc.
Date: February 26, 2021	By:	/s/ Corby Marshall
		Corby Marshall, Chief Executive Officer
		Principal Executive Officer
Date: February 26, 2021	By:	/s/ Christopher Mulgrew
		Christopher Mulgrew, Chief Financial Officer
		Principal Financial Officer

22

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Corby Marshall, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Hawkeye Systems, Inc. (the "Registrant");
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

February 26, 2021	/s/ Corby Marshall
	Corby Marshall
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, Christopher Mulgrew, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Hawkeye Systems, Inc. (the "Registrant");
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

February 26, 2021	/s/ Christopher Mulgrew
	Christopher Mulgrew
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the "Company") on Form 10-Q for the three month period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Corby Marshall, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

February 26, 2021	/s/ Corby Marshall
	Corby Marshall
	Chief Executive Officer
	(Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hawkeye Systems, Inc. (the "Company") on Form 10-Q for the three period ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Christopher Mulgrew, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company

February 26, 2021	/s/ Christopher Mulgrew
	Christopher Mulgrew
	Chief Financial Officer
	(Principal Financial Officer)

XML

Cover - shares	3 Months Ended
	Sep. 30, 2020	Feb. 23, 2021
Cover [Abstract]
Entity Registrant Name	Hawkeye Systems, Inc.
Entity Central Index Key	0001750777
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	No
Document Period End Date	Sep. 30, 2020
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		16,649,659
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	No

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Current assets:
Cash	$ 51,256	$ 911,747
Accounts receivable	49,471	47,656
Inventory, net	1,371,066	509,517
Prepaid expenses	19,879	6,667
Total current assets	1,491,672	1,475,587
Equipment, net	135	737
Note receivable - Radiant Images, Inc., net of allowance of $1,459,842	0	0
Total assets	1,491,807	1,476,324
Current liabilities:
Accounts payable and accrued liabilities	517,410	332,327
Convertible note payable, net of discount	0	137,625
Convertible note payable, net of discount - related party	224,204	211,305
Note payable - related parties	0	200,000
Common stock payable	9,000	6,000
Common stock payable - related parties	630,000	430,000
Total current liabilities	1,380,614	1,317,257
Total liabilities	1,380,614	1,317,257
Stockholders' equity:
Preferred stock, $0.0001 par value, 50,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.0001 par value, 400,000,000 shares authorized; 15,837,659 and 14,828,036 shares issued and outstanding, respectively	1,584	1,483
Additional paid-in capital	6,934,597	4,527,925
Common stock to be issued - 60,000 and 425,000 shares, respectively	30,000	139,500
Accumulated deficit	(6,854,988)	(4,509,841)
Total stockholders' equity	111,193	159,067
Total liabilities and stockholders' equity	$ 1,491,807	$ 1,476,324

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2020	Sep. 30, 2019
Non Current liabilities:
Note receivable, net of allowance	$ 1,459,842	$ 0
Stockholder's Equity
Preferred stock, shares par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	15,837,659	14,828,036
Common stock, shares outstanding	15,837,659	14,828,036
Common stock to be issued shares	60,000	425,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
Sales	$ 382,346	$ 0
Cost of sales	320,379	0
Gross profit	61,967	0
Operating expenses:
General and administrative	13,797	18,412
Management compensation	153,662	0
Professional fees	38,024	290,485
Professional fees - related party	139,340	0
Marketing	48,418	0
Write-down of inventory	40,164	0
Total operating expenses	433,405	308,897
Loss from operations	(371,438)	(308,897)
Other expense:
Interest expense	(26,833)	0
Interest expense - related party	(12,899)	0
Financing expense	(55,497)	0
Financing expense - related party	(1,508,211)	0
Loss on settlement of debt	(370,269)	0
Total other expense	(1,973,709)	0
Net loss	$ (2,345,147)	$ (308,897)
Net loss per common share - basic and diluted	$ (0.15)	$ (0.03)
Weighted average common shares outstanding - basic and diluted	15,562,663	11,164,921

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Common Stock To Be Issued [Member]	Accumulated Deficit [Member]
Balance, shares at Jun. 30, 2019		9,897,116
Balance, amount at Jun. 30, 2019	$ 460,508	$ 990	$ 2,198,891	$ 170,000	$ (1,909,373)
Common stock issued for cash, shares		449,333
Common stock issued for cash, amount	40,583	$ 45	40,538	0	0
Common stock issued as compensation, shares		1,222,000
Common stock issued as compensation, amount	540,988	$ 116	540,872	0	0
Warrants issued, shares		617,333
Warrants issued, amount	7,511	$ 0	7,511	0	0
Stock options, shares		100,000
Stock options, amount	1,918	$ 0	1,918	0	0
Stock subscription received	43,000	0	0	43,000	0
Stock subscription receivable	(2,787)	0	0	(2,787)	0
Net loss	(308,897)	$ 0	0	0	(308,897)
Balance, shares at Sep. 30, 2019		12,285,782
Balance, amount at Sep. 30, 2019	782,824	$ 1,151	2,789,730	210,213	(2,218,270)
Balance, shares at Jun. 30, 2020		14,828,036
Balance, amount at Jun. 30, 2020	159,067	$ 1,483	4,527,925	139,500	(4,509,841)
Stock subscription receivable	0
Net loss	(2,345,147)	$ 0			(2,345,147)
Common shares issued for stock to be issued, shares		365,000
Common shares issued for stock to be issued, amount	0	$ 37	109,463	(109,500)
Warrants exercised for cash, shares		175,000
Warrants exercised for cash, amount	67,500	$ 17	67,483	0	0
Common shares issued for conversion of debt, shares		469,623
Common shares issued for conversion of debt, amount	525,978	$ 47	525,931	0	0
Stock based compensation - options	119,155	0	119,155	0	0
Stock based compensation - warrant	1,563,708	0	1,563,708	0	0
Debt forgiveness	20,932	$ 0	20,932	0	0
Balance, shares at Sep. 30, 2020		15,837,659
Balance, amount at Sep. 30, 2020	$ 111,193	$ 1,584	$ 6,934,597	$ 30,000	$ (6,854,988)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (2,345,147)	$ (308,897)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	602	603
Write-down of inventory	40,164	0
Loss on settlement of debt	370,269	0
Amortization of debt discount	25,274	0
Stock based compensation - options and warrant	1,682,863	0
Common stock issued and warrants exercised for services	0	260,000
Change in operating assets and liabilities:
Accounts receivable	(1,815)	0
Inventory	(901,713)	0
Prepaid expense	(13,212)	4,855
Accounts payable and accrued liabilities	211,724	(20,369)
Common stock payable	3,000	0
Net cash used in operating activities	(927,991)	(63,808)
Cash flows from investing activities:
Shares issued for Radiant Images, Inc. deposit	0	70,000
Investment in Radiant Images, Inc.	0	(114,000)
Net cash used in investing activities	0	(44,000)
Cash flows from financing activities:
Sales of common stock and warrants, net of issuance costs	0	50,000
Proceeds from exercise of warrants	67,500	0
Stock subscription receivable	0	(2,787)
Stock subscriptions received	0	43,000
Net cash provided by financing activities	67,500	90,213
Net change in cash	(860,491)	(17,595)
Cash beginning of period	911,747	18,372
Cash end of period	51,256	777
Supplemental cash flow information
Cash paid for interest	0	0
Cash paid for taxes	0	0
Non-cash investing and financing activities:
Common stock issued on conversion of note payable	525,978	0
Reclassification from note payable related party to stock payable	200,000	0
Reclassification from common stock to be issued to common stock	109,500	0
Debt forgiveness	$ 20,932	$ 0

XML

Summary of Significant Accounting Policies

3 Months Ended

Sep. 30, 2020

Summary of Significant Accounting Policies

Note 1 - Summary of Significant Accounting Policies

Basis of presentation

The accompanying unaudited condensed interim financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2020, as filed with the SEC on February 1, 2021.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

Accounts receivable and allowance for doubtful accounts

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in its existing accounts receivable. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments for services or goods. Accounts with known financial issues are first reviewed and specific estimates are recorded. The remaining accounts receivable balances are then grouped in categories by the number of days the balance is past due, and the estimated loss is calculated as a percentage of the total category based upon past history. Account balances are charged against the allowance when it is probable that the receivable will not be recovered. The Company had no allowance for doubtful accounts at September 30, 2020 or June 30, 2020.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

Revenue is recorded in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Revenue is recognized from product sales when goods are shipped, title and risk of loss have transferred to the purchaser, there are no significant vendor obligations, the fees are fixed or determinable, and collection is reasonably assured. Amounts billed to customers for shipping and handling are included in net sales. Costs associated with shipping and handling are included in cost of goods sold. The Company recognizes sales on a gross basis when it is considered the primary obligor in the transaction and on a net basis when it is considered to be acting as an agent. We record estimates for cash discounts, product returns, and other discounts in the period of the sale. This provision is recorded as a reduction from gross sales and the reserves are shown as a reduction of accounts receivable.

Cost of sales

Cost of sales includes inventory costs and shipping and freight expenses.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable. For the three months ended September 30, 2020 and 2019, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	September 30,		September 30,
	2020		2019
Warrants		8,939,131		15,272,997
Options		5,255,000		772,000
Convertible notes		1,000,000		200,000
Total possible dilutive shares		15,194,131		16,244,997

Reclassification

Certain amounts from prior periods have been reclassified to conform to the current period presentation. The reclassification have no effect on previously reported results of operations or cash flows.

Recent Accounting Pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

XML

Going Concern

3 Months Ended

Sep. 30, 2020

Going Concern

Note 2 - Going Concern

The Company’s unaudited condensed consolidated financial statements are prepared using GAAP, applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. During the three month period ended September 30, 2020, the Company had a net loss of $2,345,147. As of September 30, 2020, the Company had an accumulated deficit of $6,854,988. The Company has not established sufficient revenue to cover its operating costs and will require additional capital to continue its operating plan. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt about its ability to continue as a going concern.

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan to obtain such resources for the Company includes: sales of equity instruments; traditional financing, such as loans; and obtaining capital from management and significant stockholders sufficient to meet its minimum operating expenses. However, management cannot provide any assurance that the Company will be successful in accomplishing this plan. 

There is no assurance that the Company will be able to obtain sufficient additional funds when needed or that such funds, if available, will be obtainable on terms satisfactory to the Company. In addition, profitability will ultimately depend upon the level of revenues received from business operations. However, there is no assurance that the Company will attain profitability. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

XML

Inventory

3 Months Ended

Sep. 30, 2020

Inventory

Note 3 - Inventory

Inventory at September 30, 2020 and June 30, 2020 consists of the following:

	September 30,			June 30,
	2020			2020
Finished goods	$	1,537,230		$	545,112
Goods in transit		-			90,405
Less: Obsolescence		(166,164	)		(126,000	)
Inventory, net	$	1,371,066		$	509,517

During the year ended June 30, 2020, the Company purchased inventory of $153,000 for issuance of common stock. As at September 30, 2020 and June 30, 2020, the Company recorded $153,000 common stock payable.

XML

Advances to Radiant Images, Inc.

3 Months Ended

Sep. 30, 2020

Advances to Radiant Images, Inc.

Note 4 - Advances to Radiant Images, Inc.

Note Receivable – Radiant Images, Inc.

In contemplation of the closing of the Radiant Agreement, the advance balance of $920,800 was formalized in a secured revolving promissory note (“Radiant Note)” dated April 26, 2019. Further advances to Radiant prior to the closing of the acquisition would increase the balance of the promissory note. The interest rate on the note was 12% and accrues daily on the outstanding balance and is collateralized by all of the assets of Radiant pursuant to a Security Agreement. The purchase price would be offset by the balance of the promissory note and interest upon closing. Through June 30, 2020, additional cash advances under the note receivable totaled $385,000 in equity-related transactions.

In April 2020, the Company received notice from Radiant of its intent to terminate the Radiant Agreement. As per terms of the agreement, the Radiant Note and related interest became due. The Company has ceased further discussions with respect to the acquisition and is pursuing litigation for repayment of amounts due by Radiant. The Company’s investment in Radiant was structured as a revolving note and has been classified as a Note Receivable from Radiant due with accrued but unpaid interest. Pursuant to the terms of the revolving note, Radiant is required to repay the money already invested to Hawkeye with interest. The note receivable was issued on April 26, 2019, is due upon demand of the Company at any time commencing April 26, 2020. The interest rate on the note is 12% and accrues daily on the outstanding balance. During the fiscal year ended June 30, 2020, total contributions of $337,000 were made to Radiant, bringing the balance of the note receivable to $1,305,800 at June 30, 2020 (not including interest). Because of the ongoing litigation with Radiant, the Company recorded an allowance for note receivable of $1,305,800 and interest receivable of $154,042, during the year ended June 30, 2020. The Company has not calculated any additional interest or allowance for the three months ended September 30, 2020. Nevertheless, the Company intends to vigorously pursue the litigation and expects to fully collect these amounts from Radiant and/or its principals.

As of September 30, 2020 and June 30, 2020, note receivable and interest receivable are as follows:

	September 30,			June 30,
	2020			2020
Note receivable	$	1,305,800		$	1,305,800
Interest receivable		154,042			154,042
		1,459,842			1,459,842
Allowance for note receivable		(1,305,800	)		(1,305,800	)
Allowance for interest receivable		(154,042	)		(154,042	)
	$	-		$	-

XML

Note Payable - Related Party

3 Months Ended

Sep. 30, 2020

Note Payable - Related Party

Note 5 - Note Payable - Related Party

On June 13, 2019, the Company entered into a Securities Purchase Agreement with a shareholder pursuant to which it issued a Promissory Note for $200,000 due on the second anniversary of issuance. The note bears interest at 10%. In connection with the Securities Purchase Agreement, the Company issued 100,000 shares of its common stock and a warrant to purchase 400,000 shares at $1.50 per share exercisable for two years from issuance.

On June 13, 2020, the note matured, became due on demand and as a condition of maturity became convertible with a 40% discount to market price, but not lower than $1.00 per share.

On July 1, 2020, the Company and note holder agreed to convert the note of $200,000 into 800,000 shares of common stock and accrued interest of $20,932 was forgiven. As a result, the Company reclassed note payable – related party of $200,000 to common stock payable and recorded debt forgiveness of $20,932 as additional paid in capital.

XML

Convertible Notes Payable

3 Months Ended

Sep. 30, 2020

Convertible Notes Payable

Note 6 - Convertible Notes Payable

Convertible note

On March 17, 2020, the Company entered into a Securities Purchase Agreement with Eagle Equities LLC pursuant to which the Company issued a 10% Convertible Redeemable Note (“Convertible Note”) for the original principal amount of $150,000. The Convertible Note is due on March 17, 2021 and on the sixth month anniversary of the Note may be converted into shares of Common Stock of the Company at a 40% discount to the lowest Volume Weighted Average Price for the Company’s common stock for the 15 days preceding the conversion. The Convertible Note may be prepaid prior to the six-month anniversary at 115% of the face if paid within 30 days, and an additional 5% every 30 days thereafter with a cap of 140%. Interest accrual and debt amortization would have begun in April 2020.

Financing fees associated with the note totaled $16,500 resulting in net proceeds to the Company of $133,500. The financing fees were recognized as a discount on debt is being amortized over the term of the note.

On August 4, 2020, the note of $150,000 and accrued interest of $5,708 were converted into 469,623 shares of common stock resulting in a loss of settlement of debt totaling $370,269.

During the three months ended September 30, 2020, amortization of $12,375 was recognized as interest expense. As of September 30, 2020 and June 30, 2020, the balance of the note payable is $0 and $150,000 less unamortized debt discount of $0 and $12,375, respectively. Interest expense of $1,958 was recognized on the convertible note during the three months ended September 30, 2020.

 Convertible note – related party

On April 6, 2020, the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on April 6, 2021. At the option of holder, this note is convertible at any time which is six months from the date of issuance through that date which is one year from the date of issuance at a conversion price of $0.25 per share. In consideration for the loan of $250,000, the Borrower also granted to the Lender 100,000 stock options exercisable at $0.25 for a two-year term. The options vested upon issuance. The fair value of the options was $13,297 and was recognized as debt discount as a part of beneficial conversion feature in the year ended June 30, 2020. The Company recorded a discount on the convertible note due to a beneficial conversion feature of $51,594, which is being amortized over the term of the note.

During the three months ended September 30, 2020, amortization of $12,899 was recognized as interest expense. As of September 30, 2020 and June 30, 2020, the balance of the note payable is $250,000 less unamortized debt discount of $25,796 and $38,695 or $224,204 and $211,305, respectively. Interest expense of $12,500 was recognized on the convertible notes during the three months ended September 30, 2020.

XML

Common stock payable

3 Months Ended

Sep. 30, 2020

Common stock payable

Note 6 - Common stock payable

As of September 30, 2020 and June 30, 2020, common stock payable are as follows:

	September 30,		June 30,
	2020		2020
Purchase of inventory – related party	$	153,000	$	153,000
Related parties		477,000		277,000
Commitments		9,000		6,000
	$	639,000	$	436,000

XML

Stockholders Equity

3 Months Ended

Sep. 30, 2020

Stockholders' equity:

Note 8 - Stockholders' Equity

Common Stock

During the three months ended September 30, 2020, the Company had the following common stock transactions:

• Issued 469,623 shares of its common stock in exchange for conversion of debt and accrued interest of $525,978.

• Issued 175,000 shares of its common stock associated with the exercise of warrants for $67,500.

• Issued 365,000 shares of common stock for stock subscriptions of $109,500 received prior to June 30, 2020.

During the three months ended September 30, 2019 the Company had the following common stock transactions:

• Effective July 3, 2019 the Company issued 333,333 shares to an accredited investor for $50,000. As part of the investment, the investor was also issued 333,333 warrants to purchase shares of common stock for two years at $.50 per share and 100,000 options to purchase shares of common stock for two years at $.25 per share

• On July 19, 2019 the Company issued 260,000 shares to Michael Mansouri and 260,000 shares to Gianna Wolfe as consulting expense in connection with the acquisition of Radiant Images, Inc.

• Effective July 28, 2019 the Company issued 200,000 shares to a related party in consideration for the payment of $50,000 to the Joint Venture, 80,000 shares to an accredited investor in consideration for $20,000 paid on behalf of the Joint Venture, and 22,000 shares to a related party for legal services valued at $11,000.

• On August 2, 2019 the investor who acquired a note on January 22, 2019 converted that note to 400,000 shares of common stock.

• Effective July 9, 2019 an investor subscribed to purchase: (i) 60,000 shares of common stock, and (ii) 60,000 Series C Warrants that are exercisable for 2 years from this date for an exercise price of $.50 per share. The purchase is at a price of $.25 per unit, for a total purchase price of $15,000, of which $2,787 was receivable at September 30, 2019.

• On September 10, 2019 the Company sold 56,000 shares to an accredited investor for $28,000. Included with the purchase was warrants to 112,000 shares at $1.00 per year for two years and warrants to purchase 112,000 shares at $2.00 per year for two years.

Common Stock to be Issued

As of September 30, 2020 and June 30, 2020, the Company received payment for unissued capital stock resulting in 60,000 and 425,000 share of common stock to be issued for payments of $30,000 and $139,500, respectively.

Balance at June 30, 2020		139,500
Received on subscription		-
Common stock certificates issued		(109,500	)
Balance at September 30, 2020	$	30,000

Stock Purchase Warrants

Transactions in stock purchase warrants for the three months ended September 30, 2020 are as follows:

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2020		7,047,135		$	1.52
Granted		2,178,996		$	1.10
Exercised – shares issued		(175,000	)	$	0.39
Expired		(112,000	)	$	1.00
Balance at September 30, 2020		8,939,131		$	1.57

The composition of the Company’s warrants outstanding at September 30, 2020 are as follows:

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		349,998		3,58
$	0.50		1,059,999		2.53
$	1.00		3,097,317		1.25
$	1.50		20,000		1.00
$	2.00		4,260,666		1.44
$	2.50		151,151		0.27
			8,939,131		1.57

During the three months ended September 30, 2020, the Company issued 2,178,996 warrants to purchase common stock. The fair value of the warrants was determined using the Black-Scholes option pricing model with the following assumptions:

	Three months ended September 30, 2020			Year ended June 30, 2020			Year ended June 30, 2019
Exercise price	$	0.30 to 2.00		$	1.00		$	1.00 to $2.00
Expected term (in years)	0.04 – 2.00 years			1.00 years			0.75 years
Risk-free rate	0.12 – 0.17		%	0.13 to 0.18		%		2.00	%
Volatility	440 - 660		%	111 to 190		%		233	%
Dividend yield		-			-			-

During the three months ended September 30, 2020, $1,563,708 was expensed for the extension of warrants that had expired, of which $1,508,211 was to a related party.

Stock Options

During the three months ended September 30, 2020 and year ended June 30, 2020, 0 and 3,800,000 options were granted, respectively.

The fair value of the options was determined using the Black-Scholes option pricing model with the following assumptions:

	June 30,
	2020
Trading price	$	0.06-$0.47
Exercise price	$	0.10-$0.50
Expected term (in years)	1.0 to 5.0
Risk-free rate	0.19%-2.46
Volatility	97%-174
Dividend yield		-

The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of the awards in effect at the time of grant. The Company has no history or expectation of paying cash dividends on its common stock.

Transactions in stock options for the three months ended September 30, 2020 are as follows:

	Number of options		Weighted average exercise price		Weighted average remaining life (in years)
Outstanding, June 30, 2020		5,255,000	$	0.25		4.28
Granted		-		-		-
Expired or Forfeited		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2020		5,255,000		0.25		4.03
Vested, September 30, 2020		3,815,000	$	0.29		3.86

During the three months ended September 30, 2020, $119,155 was expensed, of which $85,100 was to related parties, and as of September 30, 2020, $238,307 remains unamortized, of which $170,198 is with related parties.

At September 30, 2020, the intrinsic value of the 5,255,000 outstanding options was $1,424,127.

XML

Related Party Transactions

3 Months Ended

Sep. 30, 2020

Related Party Transactions

Note 9 - Related Party Transactions

As of September 30, 2020 and June 30, 2020, the Company recorded $277,000 in common stock payable to a related party investor.

XML

Commitments and Contingencies

3 Months Ended

Sep. 30, 2020

Commitments and Contingencies

Note 10 - Commitments and Contingencies

On August 1, 2019, the Company entered into an agreement with Stratcon Advisory and Tysadco Partners. Pursuant to the agreement, the Company will pay $6,000 per month for twelve months for corporate development, investment advisory, and investor relations services, payable $3,000 in restricted common stock and $3,000 in cash. Total expense recognized under this agreement during the three months ended September 30, 2020 and 2019 was $6,000 and $12,000, respectively. As of September 30, 2020 and June 30, 2020, the Company had a balance of $30,000 and $27,000 in accounts payable and $9,000 and $6,000 worth of common stock payable, respectively.

On June 11, 2020, the Company formalized an employment agreement with its chief executive officer which provides for annual salary of $250,000 beginning with the calendar year 2020. The agreement also specified that the CEO would receive $180,000 of salary that was earned during the calendar year 2019. During the three months ended September 30, 2020, compensation expense of $30,000 was recognized under this agreement. As of September 30, 2020 and June 30, 2020, the Company has a payable due to its CEO of $30,000 and $150,000, respectively. The agreement contained provisions for severance, health benefits, and a car allowance.

XML

Subsequent Events

3 Months Ended

Sep. 30, 2020

Subsequent Events

Note 11 - Subsequent Events

Effective November 25, 2020, the Company’s chief executive officer converted $180,000 of unpaid salary into 515,000 shares of common stock.

Effective December 3, 2020, the Company issued 100,000 shares of common stock to an accredited investor for $20,000. Included with the purchase were 100,000 options to purchase common stock at $0.20 per share exercisable for two years.

Effective December 15, 2020, the Company issued 612,000 shares of common stock to an accredited investor upon conversion of $153,000 in debt.

Effective December 15, 2020, the Company issued a 1 year convertible promissory note for $250,000. The promissory note incurs interest at 10%, if repaid within 90 days, and simple interest at 20% per annum thereafter. At the option of the holder this note is convertible at any time which is six months from the date of the issuance through the date which is one year from the date of issuance at a conversion price of $0.25 per share. Included with the convertible promissory note were 100,000 options to purchase common stock at $0.25 per share exercisable for two years.

On February 19, 2021, a related party advanced $1 million to the Company. The purpose of the advance is to purchase inventory to satisfy a customer order. The advance will be repaid upon cash being received from the end customer. In addition to the principal amount of the advance, the related party will be entitled to 1/3 of the gross profit earned on the transaction.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Sep. 30, 2020

Summary of Significant Accounting Policies

Basis of presentation

The accompanying unaudited condensed interim financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited condensed interim financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the unaudited condensed interim financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited condensed interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended June 30, 2020, as filed with the SEC on February 1, 2021.

Use of estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. Significant estimates in the accompanying financial statements include useful lives of property and equipment, fair value assumptions used for stock-based compensation, and the valuation allowance on deferred tax assets.

Accounts receivable and allowance for doubtful accounts

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in its existing accounts receivable. The Company maintains allowances for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments for services or goods. Accounts with known financial issues are first reviewed and specific estimates are recorded. The remaining accounts receivable balances are then grouped in categories by the number of days the balance is past due, and the estimated loss is calculated as a percentage of the total category based upon past history. Account balances are charged against the allowance when it is probable that the receivable will not be recovered. The Company had no allowance for doubtful accounts at September 30, 2020 or June 30, 2020.

Fair value measurements

When required to measure assets or liabilities at fair value, the Company uses a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used. The Company determines the level within the fair value hierarchy in which the fair value measurements in their entirety fall. The categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Level 1 uses quoted prices in active markets for identical assets or liabilities, Level 2 uses significant other observable inputs, and Level 3 uses significant unobservable inputs. The amount of the total gains or losses for the period are included in earnings that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date. The Company has no assets or liabilities that are adjusted to fair value on a recurring basis.

Revenue recognition

Revenue is recorded in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”). Revenue is recognized from product sales when goods are shipped, title and risk of loss have transferred to the purchaser, there are no significant vendor obligations, the fees are fixed or determinable, and collection is reasonably assured. Amounts billed to customers for shipping and handling are included in net sales. Costs associated with shipping and handling are included in cost of goods sold. The Company recognizes sales on a gross basis when it is considered the primary obligor in the transaction and on a net basis when it is considered to be acting as an agent. We record estimates for cash discounts, product returns, and other discounts in the period of the sale. This provision is recorded as a reduction from gross sales and the reserves are shown as a reduction of accounts receivable.

Cost of sales

Cost of sales includes inventory costs and shipping and freight expenses.

Basic and diluted earnings per share

Basic earnings per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including stock options, warrants to purchase the Company’s common stock, and convertible note payable. For the three months ended September 30, 2020 and 2019, potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share because they were anti-dilutive are as follows:

	September 30,		September 30,
	2020		2019
Warrants		8,939,131		15,272,997
Options		5,255,000		772,000
Convertible notes		1,000,000		200,000
Total possible dilutive shares		15,194,131		16,244,997

Reclassifications

Certain amounts from prior periods have been reclassified to conform to the current period presentation. The reclassification have no effect on previously reported results of operations or cash flows.

Recent accounting pronouncements

Management has considered all recent accounting pronouncements issued and their potential effect on our financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed consolidated financial statements.

XML

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2020

Summary of Significant Accounting Policies

Schedule Of Basic and Diluted Earnings Per Share

	September 30,		September 30,
	2020		2019
Warrants		8,939,131		15,272,997
Options		5,255,000		772,000
Convertible notes		1,000,000		200,000
Total possible dilutive shares		15,194,131		16,244,997

XML

Inventory (Tables)

3 Months Ended

Sep. 30, 2020

Inventory

Schedule of inventry

	September 30,			June 30,
	2020			2020
Finished goods	$	1,537,230		$	545,112
Goods in transit		-			90,405
Less: Obsolescence		(166,164	)		(126,000	)
Inventory, net	$	1,371,066		$	509,517

XML

Advances to Radiant Images, Inc. (Tables)

3 Months Ended

Sep. 30, 2020

Advances to Radiant Images, Inc.

Schdeule of note receivable and interest receivable

	September 30,			June 30,
	2020			2020
Note receivable	$	1,305,800		$	1,305,800
Interest receivable		154,042			154,042
		1,459,842			1,459,842
Allowance for note receivable		(1,305,800	)		(1,305,800	)
Allowance for interest receivable		(154,042	)		(154,042	)
	$	-		$	-

XML

Common stock payable (Tables)

3 Months Ended

Sep. 30, 2020

Convertible Notes Payable

Note 6 - Common stock payable

As of September 30, 2020 and June 30, 2020, common stock payable are as follows:

	September 30,		June 30,
	2020		2020
Purchase of inventory – related party	$	153,000	$	153,000
Related parties		477,000		277,000
Commitments		9,000		6,000
	$	639,000	$	436,000

XML

Stockholders Equity (Tables)

3 Months Ended

Sep. 30, 2020

Schedule of payment received for unissued capital stock

Balance at June 30, 2020		139,500
Received on subscription		-
Common stock certificates issued		(109,500	)
Balance at September 30, 2020	$	30,000

Schedule of financial derivative activity

	Number of			Weighted Average
	Warrants			Exercise Price
Balance at June 30, 2020		7,047,135		$	1.52
Granted		2,178,996		$	1.10
Exercised – shares issued		(175,000	)	$	0.39
Expired		(112,000	)	$	1.00
Balance at September 30, 2020		8,939,131		$	1.57

Schedule of warrants outstanding

Exercise Price		Number of Warrants		Weighted Average Remaining Life (in years)
$	0.30		349,998		3,58
$	0.50		1,059,999		2.53
$	1.00		3,097,317		1.25
$	1.50		20,000		1.00
$	2.00		4,260,666		1.44
$	2.50		151,151		0.27
			8,939,131		1.57

Schedule of fair value of derivatives

	Three months ended September 30, 2020			Year ended June 30, 2020			Year ended June 30, 2019
Exercise price	$	0.30 to 2.00		$	1.00		$	1.00 to $2.00
Expected term (in years)	0.04 – 2.00 years			1.00 years			0.75 years
Risk-free rate	0.12 – 0.17		%	0.13 to 0.18		%		2.00	%
Volatility	440 - 660		%	111 to 190		%		233	%
Dividend yield		-			-			-

Stock options [Member]

Schedule of financial derivative activity

	Number of options		Weighted average exercise price		Weighted average remaining life (in years)
Outstanding, June 30, 2020		5,255,000	$	0.25		4.28
Granted		-		-		-
Expired or Forfeited		-		-		-
Exercised		-		-		-
Outstanding, September 30, 2020		5,255,000		0.25		4.03
Vested, September 30, 2020		3,815,000	$	0.29		3.86

Schedule of fair value of derivatives

	June 30,
	2020
Trading price	$	0.06-$0.47
Exercise price	$	0.10-$0.50
Expected term (in years)	1.0 to 5.0
Risk-free rate	0.19%-2.46
Volatility	97%-174
Dividend yield		-

XML

Summary of Significant Accounting Policies (Details) - shares	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Total possible dilutive shares	15,194,131	16,244,997
Convertible Notes [Member]
Total possible dilutive shares	1,000,000	200,000
Options [Member]
Total possible dilutive shares	5,255,000	772,000
Warrant [Member]
Total possible dilutive shares	8,939,131	15,272,997

XML

Going Concern (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Going Concern
Accumulated deficit	$ (6,854,988)	$ (4,509,841)
Net loss	$ (2,345,147)

XML

Inventory (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Inventory
Finished goods	$ 1,537,230	$ 545,112
Goods in transit	0	90,405
Less: Obsolescence	(166,164)	(126,000)
Inventory, Net	$ 1,371,066	$ 509,517

XML

Inventory (Details Narrative) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Inventory purchased	$ 153,000	$ 153,000
Common stock payable	9,000	6,000
Purchase of inventory - related party [Member]
Common stock payable	$ 153,000	$ 153,000

XML

Advances to Radiant Images, Inc. (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Note receivable	$ 0	$ 0
Joint Venture Agreement [Member]
Note receivable	1,305,800	1,305,800
Interest receivable	154,042	154,042
Total receivables	1,459,842	1,459,842
Allowance for note receivable	(1,305,800)	(1,305,800)
Allowance for interest receivable	(154,042)	(154,042)
Total Allowance for receivable	$ 0	$ 0

XML

Advances to Radiant Images, Inc. (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Apr. 26, 2019	Jun. 30, 2020
Radiant Images, Inc [Member]
Description of radiant note	In contemplation of the closing of the Radiant Agreement, the advance balance of $920,800 was formalized in a secured revolving promissory note (“Radiant Note)” dated April 26, 2019.
Additional cash advances		$ 385,000
Advances to Radiant Images, Inc.	$ 920,800
Radiant Agreement [Member] | April 2020 [Member]
Interest rate		12.00%
Total contribution		$ 337,000
Note receivable		1,305,800
Allowance for note receivable		1,305,800
Allowance for interest receivable		$ 154,042

XML

Notes Payable Related Party (Details Narrative) - USD ($)		3 Months Ended
	Jun. 13, 2019	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020
Note payable - related parties		$ 0		$ 200,000
Debt forgiveness		$ 20,932	$ 0
July 1 2020 [Member]
Conversion of common stock, shares		800,000
Conversion of common stock, amount		$ 200,000
Note payable - related parties		200,000
Debt forgiveness		20,932
Accrued interest forgiven		$ 20,932
Securities Purchase Agreement [Member] | On June 13, 2019 [Member]
Related Party Note 2	$ 200,000
Origination shares issued	100,000
Purchase shares of warrant	400,000
Debt instrument interest rate	10.00%
Purchase price per share	$ 1.50
Term of debt, description	On June 13, 2020, the note matured and became due on demand and became convertible with a 40% discount to market price, but not lower than $1.00 per share.

XML

Convertible Notes Payable (Details Narrative) - USD ($)			3 Months Ended
	Aug. 04, 2020	Apr. 06, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020
Note payable, net of discount			$ 224,204		$ 211,305
Finance fees			16,500
Amortization of interest expense			12,899
Unamortized debt discount			25,796		38,695
Notes payable, balance			250,000		250,000
Interest expense			12,500
Notes payable descriptions		the Company issued convertible note payable of $250,000 with simple interest at 10% per annum if repaid within 90 days, and simple interest at 20% per annum thereafter. The convertible note is due on April 6, 2021.
Conversion price		$ 0.25
Net proceeds of the fees			133,500
Note issued		$ 250,000
Debt forgiveness			$ 20,932	$ 0
Securities Purchase Agreement [Member] | March 17, 2020 [Member]
Maturity date			Mar. 17, 2021
Debt instrument descriptions			Note may be converted into shares of Common Stock of the Company at a 40% discount to the lowest Volume Weighted Average Price for the Company’s common stock for the 15 days preceding the conversion. The Company will recognize the derivative liability when the Note becomes convertible. The Convertible Note may be prepaid prior to the six-month anniversary at 115% of the face if paid within 30 days, and an additional 5% every 30 days thereafter with a cap of 140%. Interest accrual and debt amortization would have begun in April 2020.
Debt instrument principal amount			$ 150,000
Lender [Member]
Consideration amount		$ 250,000
Stock option exercisable		100,000
Exercisable price		$ 0.25
Term of option		2 years
Fair value of options			13,297
Beneficial conversion feature			51,594
Convertible Notes [Member]
Amortization of interest expense			12,375
Unamortized debt discount			0		12,375
Notes payable, balance			0		$ 150,000
Interest expense			$ 1,958
Debt conversion, converted instrument, amount	$ 150,000
Debt conversion, converted instrument, shares issued	469,623
Accrued interest	$ 5,708
Debt forgiveness	$ 370,269

XML

Common stock payable (Details) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Common stock payable	$ 639,000	$ 436,000
Purchase of inventory - related party [Member]
Common stock payable	153,000	153,000
Related Parties [Member]
Common stock payable	477,000	277,000
Commitments [Member]
Common stock payable	$ 9,000	$ 6,000

XML

Stockholders Equity (Details)	3 Months Ended
	Sep. 30, 2020 USD ($)
Stockholders' equity:
Beginning balance	$ 139,500
Received on subscription	0
Common stock certificates issued	(109,500)
Ending balance	$ 30,000

XML

Stockholders Equity (Details1) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020
Warrant Shares
Warrant shares, Granted	0	3,800,000
Warrant [Member]
Warrant Shares
Warrants shares, beginnig balance	7,047,135
Warrant shares, Granted	2,178,996
Warrant shares, Exercised - shares issued	(175,000)
Warrant shares, expired	$ (112,000)
Warrants shares, ending balance	8,939,131	7,047,135
Weighted Average Exercise Price
Weighted average exercise price, beginning	$ 1.52
Weighted average exercise price, Granted	1.10
Weighted average exercise price, Exercised	0.39
Weighted average exercise price, Expired	1.00
Weighted average exercise price, Ending	$ 1.57	$ 1.52

XML

Stockholders Equity (Details 2)	3 Months Ended
	Sep. 30, 2020 $ / shares shares
Number of Warrants	8,939,131
Weighted Average Remaining Life (in years)	1 year 6 months 26 days
Warrants outsanding 5 [Member]
Number of Warrants	151,151
Weighted Average Remaining Life (in years)	3 months 7 days
Exercise Price | $ / shares	$ 2.50
Warrants outsanding 4 [Member]
Number of Warrants	4,260,666
Weighted Average Remaining Life (in years)	1 year 5 months 9 days
Exercise Price | $ / shares	$ 2.00
Warrants outsanding 3 [Member]
Number of Warrants	20,000
Weighted Average Remaining Life (in years)	1 year
Exercise Price | $ / shares	$ 1.50
Warrants outsanding 2 [Member]
Number of Warrants	3,097,317
Weighted Average Remaining Life (in years)	1 year 2 months 30 days
Exercise Price | $ / shares	$ 1.00
Warrants outsanding 1 [Member]
Number of Warrants	1,059,999
Weighted Average Remaining Life (in years)	2 years 6 months 11 days
Exercise Price | $ / shares	$ 0.50
Warrants outsanding [Member]
Number of Warrants	349,998
Weighted Average Remaining Life (in years)	3 years 6 months 29 days
Exercise Price | $ / shares	$ 0.30

XML

Stockholders Equity (Details 3) - Warrant [Member] - $ / shares	3 Months Ended	12 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
Volatility:			233.00%
Dividend yield	0.00%	0.00%	0.00%
Exercise price		$ 1.00
Expected term (in years)		1 year	8 months 30 days
Risk-free rate			2.00%
Minimum [Member]
Volatility:	440.00%	111.00%
Exercise price	$ 0.30		$ 1.00
Expected term (in years)	15 days
Risk-free rate	0.12%	0.13%
Maximum [Member]
Volatility:	660.00%	190.00%
Exercise price	$ 2.00		$ 2.00
Expected term (in years)	2 years
Risk-free rate	0.17%	0.18%

XML

Stockholders Equity (Details 4)	12 Months Ended
	Jun. 30, 2020 $ / shares
Stock Option [Member] | Minimum [Member]
Exercise price	$ 0.10
Expected term (in years)	1 year
Trading price	$ 0.06
Risk-free rate	0.19%
Volatility	97.00%
Stock Option [Member] | Maximum [Member]
Exercise price	$ 0.50
Expected term (in years)	5 years
Trading price	$ 0.47
Risk-free rate	2.46%
Volatility	174.00%
Stock options [Member]
Dividend yield	0.00%

XML

Stockholders Equity (Details 5) - Stock options [Member]	3 Months Ended
	Sep. 30, 2020 $ / shares shares
Warrants shares, beginnig balance	5,255,000
Number of options, Granted
Number of options, Expired or Forfeited
Number of options, Exercised
Warrants shares, ending balance	5,255,000
Number of options, Vested	3,815,000
Weighted Average Exercise Price
Weighted average exercise price, beginning | $ / shares	$ 0.25
Weighted average exercise price, Granted | $ / shares	0
Weighted average exercise price, Ending | $ / shares	0.25
Weighted Average Exercise Price, vested | $ / shares	$ 0.29
Weighted average remaining life, beginning	4 years 3 months 11 days
Weighted average remaining life, ending	4 years 11 days
Weighted average remaining life, vested	3 years 10 months 10 days

XML

Stockholders Equity (Details Narrative) - USD ($)	1 Months Ended				3 Months Ended		12 Months Ended
	Sep. 10, 2019	Jul. 28, 2019	Jul. 19, 2019	Jul. 03, 2019	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Intrinsic shares of the outstanding options					5,255,000
Accrued interest					$ 525,978
Common stock, shares issued in exchange for convertible note payable					469,623
Common stock, shares issued for subscriptions, amount					$ 109,500
Common stock, shares issued for subscriptions, shares					365,000
Warrants exercised for cash, amount					$ 67,500
Warrants exercised for cash, shares					175,000
Intrinsic value of the outstanding options					$ 1,424,127
Unissued capital stock					60,000		425,000
Common stock to be issued for payments					$ 30,000		$ 139,500
Warrants issued to purchase common stock					2,178,996
Expensed for extension of warrants, expired					1,563,708
Stock options, expensed					119,155
Stock options, unamortized					$ 238,307
Stock options, granted					0		3,800,000
Outstanding options, intrinsic value					$ 1,424,127
Outstanding options					5,255,000
Common stock, shares issued					15,837,659	14,828,036
Common stock, value					$ 1,584		$ 1,483
Joint Venture [Member]
Common stock, shares issued		200,000
Repayment of related party		$ 50,000
Warrant [Member]
Stock options, granted					2,178,996
Expected life							1 year	8 months 30 days
Accredited Investor [Member] | Warrant One [Member]
Warrants issued to purchase common stock	$ 112,000
Common stock, price per share	$ 2.00
Accredited Investor [Member] | Warrant [Member]
Warrants issued to purchase common stock	$ 112,000
Common stock, price per share	$ 1.00
Related Party [Member]
Expensed for extension of warrants, expired					$ 1,508,211
Stock options, expensed					85,100
Stock options, unamortized					$ 170,198
Shares issued for legal services, value		$ 11,000
Shares issued for legal services, shares		22,000
Accredited Investor [Member]
Warrants issued to purchase common stock				$ 333,333
Expected life					2 years
Share issued price per share for investor two				$ 0.25
Common stock, shares issued	56,000	80,000		333,333
Common stock, value	$ 28,000			$ 50,000
Payment on behalf of joint venture		$ 20,000
Options to purchase common stock				100,000
Share issued price per share				$ 0.50
Investor [Member] | Effective July 9, 2019 [Member]
Common stock subscribed to purchase description					i) 60,000 shares of common stock, and (ii) 60,000 Series C Warrants that are exercisable for 2 years from this date for an exercise price of $.50 per share.
Common stock subscription receivable						$ 2,787
Total purchase price						$ 15,000
Purchase price per share						$ 0.25
Michael Mansouri [Member] | Radiant Images, Inc [Member]
Shares issued for acquisition			260,000
Gianna Wolfe [Member] | Radiant Images, Inc [Member]
Shares issued for acquisition			260,000

XML

Related Party Transactions (Details Narrative) - USD ($)	Sep. 30, 2020	Jun. 30, 2020
Common stock payable	$ 9,000	$ 6,000
Related Party Investor [Member]
Common stock payable	$ 277,000	$ 277,000

XML

Commitments and Contingencies (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2020
Total expenses	$ 433,405	$ 308,897
Common stock payable	639,000		$ 436,000
Chief Executive Officer [Member] | June 11 2020 [Member]
Annual salary	250,000
Salary		180,000
Accounts payable	30,000		150,000
Compensation expense	30,000
Stratco Advisory and Tysadco Partners [Member] | August 1 2019 [Member] | Development service agreement [Member]
Accounts payable	$ 30,000		27,000
Service agreement description	the Company entered into an agreement with Stratcon Advisory and Tysadco Partners. Pursuant to the agreement, the Company will pay $6,000 per month for twelve months for corporate development, investment advisory, and investor relations services, payable $3,000 in restricted common stock and $3,000 in cash
Total expenses	$ 6,000	$ 12,000
Common stock payable	$ 9,000		$ 6,000

XML

Subsequent Events (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended
	Dec. 15, 2020	Nov. 25, 2020	Dec. 03, 2020	Feb. 19, 2021	Sep. 30, 2020	Jun. 30, 2020
Common stock, value					$ 1,584	$ 1,483
Subsequent Event [Member]
Related party advance				$ 1,000,000
Subsequent Event [Member] | Accredited Investor [Member]
Exercise price	$ 0.25		$ 0.20
Conversion of debt	$ 153,000
Conversion of common stock, shares	100,000
Description of stock option plan	The promissory note incurs interest at 10%, if repaid within 90 days, and simple interest at 20% per annum thereafter. At the option of the holder this note is convertible at any time which is six months from the date of the issuance
Conversion of common stock, amount	$ 250,000
Conversion price	$ 0.25
Common Stock, shares issued	612,000		100,000
Common stock, value			$ 20,000
Options to purchase common stock			100,000
Maturity period			2 years
Subsequent Event [Member] | Chief Executive Officer [Member]
Common Stock, shares issued		515,000
Unpaid salary		$ 180,000